Janne PA, Wang BC, Cho BC, Zhao J, et al. First-Line Mobocertinib Versus Platinum-Based Chemotherapy in Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer in the Phase III EXCLAIM-2 Trial. J Clin Oncol 2025 Jan 29:JCO2401269. doi: 10.1200/JCO-24-01269.
PMID: 39879577